title: Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'e-minus' patients with YMDD mutations after 4 weeks of tenofovir therapy.
authors.forename: Raffaele
authors.initials: R
authors.lastname: Bruno
authors.forename: Paolo
authors.initials: P
authors.lastname: Sacchi
authors.forename: Cristina
authors.initials: C
authors.lastname: Zocchetti
authors.forename: Valentina
authors.initials: V
authors.lastname: Ciappina
authors.forename: Massimo
authors.initials: M
authors.lastname: Puoti
authors.forename: Gaetano
authors.initials: G
authors.lastname: Filice
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000150:complications*; D006515:Hepatitis B virus / Q000302:isolation & purification; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D000068698:Tenofovir
chemical_list: D019380:Anti-HIV Agents; D004279:DNA, Viral; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D000068698:Tenofovir; D000225:Adenine